NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research will use Geospiza’s genetic analysis software in its sequencing programs for cancer research, the company said today.
Under the agreement, Toronto-based OICR will use the company’s FinchLab software in its cancer studies. The not-for-profit institute is funded by the Ontario government under the Ministry of Research and Innovation.
In April, OICR said it received CA$60 million ($58.8 million), which it plans to spend on building up its cancer research program, starting new initiatives, and stocking up on new equipment.
The FinchLab platform will support analysis projects for data from OICR’s next-generation sequencing instruments, such as the Illumina Genome Analyzer and Applied Biosystems’ SOLiD, the Seattle-based company said.